Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amgen Surpasses Q4 Earnings Forecasts

TheMotleyFool 
0 0 04.02.25
Amgen Surpasses Q4 Earnings ForecastsPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
 

Biotechnology specialist (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS of $5.08 and revenue of $8.88 billion, but Amgen reported $5.31 in EPS and $9.1 billion in revenue, showcasing double-digit year-on-year growth in both metrics.

Overall, the quarter demonstrated Amgen's effective execution amid a competitive landscape.

Source: Amgen. Note: Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year.

Continue reading


Source Fool.com

Amgen Inc. Stock

€362.20
-0.060%
With only a change of -€0.200 (-0.060%) the Amgen Inc. price is nearly unchanged from yesterday.
The stock is one of the favorites of our community with 42 Buy predictions and 4 Sell predictions.
On the other hand, the target price of 340 € is below the current price of 362.2 € for Amgen Inc., so the potential is actually -6.13%.
Show more
Like: 0
AMGN
Share

Comments

Not a member yet? Sign up for free!